SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 26, 2002
CELLPOINT INC.
----------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Nevada 0-25205 52-2032380
----------------------------- ----------------------- -------------------------
(State or Other Jurisdiction (Commission ( I.R.S. Employer
of Incorporation) File Number) Identification No.)
3000 Hillswood Drive, Hillswood Business Park,
Chertsey, Surrey KT16 ORS, England
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: 011 44 1932 895 310
-------------------
-------------------------------------------------------------------------------
Former name or former address, if changed since last report
ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE.
Delisting of our Common Stock from The Nasdaq National Market
Effective the open of business on June 26, 2002, our common stock was delisted
from The Nasdaq National Market. Our common stock is now traded on the OTC
Bulletin Board under the symbol CLPT.OB.
The June 25, 2002 decision of the Nasdaq Listing Qualifications Panel denied our
request for continued listing on The Nasdaq National Market, basing its decision
primarily on our failure to maintain a minimum of $10,000,000 of shareholders
equity required by the Nasdaq Marketplace Rules, our common stock having closed
at a bid price of less than $1.00 per share for a 30 consecutive trading day
period and that this deficiency was not remedied in the 90-day grace period and,
finally, the fact that the market value of our publicly held shares was less
than $5,000,000.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Financial Statements
Not applicable.
(b) PRO FORMA Financial Statements
Not applicable.
(c) Exhibits
Not applicable.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Company has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
CELLPOINT INC.
By /s/ Stephen Childs
------------------------------
Stephen Childs
Chief Executive Officer
Date: June 27, 2002